Trupanion, Inc. (TRUP) Dividend History

Trupanion, Inc. is a provider of medical insurance for pets, primarily focusing on coverage for cats and dogs. Founded in 1998, the company offers a customizable health insurance plan that reimburses pet owners for veterinary expenses related to accidents, injuries, and illnesses. Trupanion operates through a subscription model and aims to improve the accessibility and affordability of veterinary care for pet owners.

6100 4th Avenue South, Seattle, WA, 98108
Phone: 888-733-2685
Website:

Dividend History

Trupanion, Inc. currently does not pay dividends

Company News

  • Top Animal Health Experts Address H5N1 Bird Flu in Trupanion Webinar

    Trupanion will host a webinar on the evolving state of bird flu (H5N1) and its impact on pets, pet parents, and the veterinary community. The webinar will feature a panel of leading animal health experts and aims to equip veterinary professionals and pet parents with the latest information and practical guidance on avian flu in pets.

    GlobeNewswire Inc.
  • Trupanion Posts Revenue Beat, EPS Miss

    Trupanion, a leader in pet medical insurance, reported mixed Q4 2024 earnings. While revenue exceeded expectations, earnings per share (EPS) fell short. However, the company showed a significant turnaround, moving from a net loss to a net income of $1.7 million.

    The Motley Fool
  • 3 Stocks With High Short Interest Still Near Their 52-Week Highs

    The article discusses three stocks - PureCycle Technologies (PCT), NuScale Power (SMR), and Trupanion (TRUP) - that have high short interest but are still trading near their 52-week highs, indicating a disconnect between bearish sentiment and stock performance.

    Investing.com
    Featured Companies: PCT SMR
  • Calling All Paw-ty Animals: Trupanion to Connect Families & Shelter Pets for a Frightfully Howling Halloween

    Trupanion is launching a pet costume contest to spotlight adoptable pets and the shelters/rescues that care for them, with the goal of connecting these pets with potential families.

    GlobeNewswire Inc.
  • What 4 Analyst Ratings Have To Say About Trupanion - Benzinga

    Four analysts have published ratings on Trupanion in the last three months, offering a range of perspectives. The average 12-month price target has increased by 8% to $33.75, with a high estimate of $49 and a low of $22. The analysts' ratings and price targets provide insights into Trupanion's market standing and performance.

    Benzinga
Dividend data last updated 06/06/2025 16:50:55 UTC